Fluence Analytics announces partnership with Nihon Rufuto
Japan | News | 0 Comment | 08 Jun, 2018
Fluence Analytics, a manufacturer of industrial and laboratory analytics products has announced that it has signed a dis...Read more
Verastem, Yakult Honsha Co. Ltd sign exclusive license agreement
Japan | News | 0 Comment | 07 Jun, 2018
Verastem, Inc. and Yakult Honsha Co., Ltd. have announced their entry into an exclusive licensing agreement for Yakult t...Read more
GHIT Fund names Hiroki Nakatani as Board Chair
Japan | News | 0 Comment | 07 Jun, 2018
The Global Health Innovative Technology (GHIT) Fund has announced the appointment of Hiroki Nakatani, MD, PhD, MHPEd, fo...Read more
USFDA grants Priority Review to Astellas's NDA for Gilteritinib
Japan | News | 0 Comment | 05 Jun, 2018
Japan’s Astellas Pharma recently announced that the U.S. Food and Drug Administration (FDA) has accepted, with Pri...Read more
Scientists use RFID chips to track biological samples
Japan | News | 0 Comment | 01 Jun, 2018
Researchers in the U.S. and Japan plan to use Radio frequency identification (RFID) chips for keeping track of organoids...Read more
Telix, Osaka University receive funding for alpha nuclide research
Japan | News | 0 Comment | 31 May, 2018
Singapore- Telix Pharmaceuticals Limited, a clinical-stage biopharmaceutical company focused on the development of diagn...Read more
Eisai, Merck provide Update on sNDA for Lenvatinib
Japan | News | 0 Comment | 25 May, 2018
Eisai Inc. and Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced that the U.S. Food and Dr...Read more
Eisai, Purdue to present latest Clinical Data on Lemborexant
Japan | News | 0 Comment | 23 May, 2018
Eisai Co., Ltd. and Purdue Pharma L.P. announced they will present the latest data from two key Phase I clinical studies...Read more
AstraZeneca submits sNDA for Forxiga in Japan
Japan | News | 0 Comment | 22 May, 2018
Global drug giant, AstraZeneca has submitted a supplemental new drug application (sNDA) to Japan’s Pharmaceuticals...Read more
Study shows new possibilities with cardiac T-high sensitive test
Japan | News | 0 Comment | 21 May, 2018
Singapore – Results published in the International Journal of Cardiology show that the 0-hour/1-hou...Read more
Takeda Divests Techpool to Joint-Venture Partners in China
Japan | News | 0 Comment | 21 May, 2018
Japan's Takeda Pharmaceutical recently announced it has entered into an agreement to sell its majority shareholding...Read more
Japan approves stem cell based trials for heart treatment
Japan | News | 0 Comment | 17 May, 2018
A special health ministry panel gave Osaka University the approval to carry out a study involving the use of induce...Read more
Platelet BioGenesis licenses induced pluripotent stem cell technology
Japan | News | 2 Comment | 14 May, 2018
Platelet BioGenesis, a pioneer in the production of functional human platelets from stem cells, has announced it has lic...Read more
Kaneka Corp. to appeal to Federal Court on Patent case
Japan | News | 0 Comment | 10 May, 2018
Kaneka Corporation, the Japan based chemical manufacturing company, is set to appeal to the District Court for the Centr...Read more
Aquinox, Astellas ink deal to develop and commercialize Rosiptor in APAC
Japan | News | 0 Comment | 10 May, 2018
Aquinox Pharmaceuticals, a clinical-stage pharmaceutical company discovering and developing novel drug candidate...Read more
Takeda clinches $62B deal to drugmaker Shire
Japan | News | 0 Comment | 08 May, 2018
Singapore– Takeda Pharmaceutical agreed to buy London-listed Shire for 45.3 billion pounds ($61.50 billion) a...Read more
Ono Pharma submits marketing approval of metyrosine in Japan
Japan | News | 0 Comment | 02 May, 2018
Japanese drugmaker Ono Pharmaceutical has submitted a new drug application for the approval of pheochromocytoma (PCC) tr...Read more
Aspirin may suppress the impact of obesity on cancer
Japan | News | 0 Comment | 30 Apr, 2018
Aspirin can counter the ill effects of obesity on cancer development, according to a study that may pave the way for new...Read more